Skip to main content
Clinical Trials/EUCTR2011-001686-40-DE
EUCTR2011-001686-40-DEActive, not recruitingNot Applicable

INTRACORONARY STENTING AND ANTITHROMBOTIC REGIMEN: ADJUSTING ANTIPLATELET TREATMENT IN PATIENTS BASED ON PLATELET FUNCTION TESTING - ISAR ADAPT-PF - ISAR ADAPT-PF

German Heart Centre Munich, Department of Cardiovascular Diseases0 sites70 target enrollmentStarted: June 6, 2011Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • - patients after coronary intervention
  • - insufficient inhibition of platelet aggregation after Clopidogrel loading
  • - informed, written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 35

Exclusion Criteria

  • - age < 18 years >, > 80 years
  • - body weight < 60 kg
  • - surgical intervention < 6 weeks
  • - apoplexy in anamnesis
  • - cardiogenic shock
  • - oral anticoagulation
  • - GPIIb/IIIa antagonists < 10 days or periprocedural
  • - platelet count < 100.000/µl
  • - increased risk for bradycardia
  • - severe liver dysfunction
  • - dialysis-dependent renal insufficiency
  • - simultaneous taking of CYP3A4 inhibitors

Investigators

Sponsor
German Heart Centre Munich, Department of Cardiovascular Diseases

Similar Trials